Anika Therapeutics Inc (NASDAQ:ANIK)

Delayed Data
As of Apr 24
 -0.32 / -0.83%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 45.50, with a high estimate of 45.50 and a low estimate of 45.50. The median estimate represents a +18.64% increase from the last price of 38.35.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -59.80%
Growthannually -45.22%


Growthquarterly -29.96%
Growthannually -20.65%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account